Moreover, the large-scale statistical analyses of patient data support that a high DSTYK level is correlated with a high probability of death in breast cancer patients, TNBC patients, and TNBC patients treated with chemotherapy only. This evidence concerns the gene DSTYK and breast carcinoma.